Skip to main content

Emergence of Covid-19 and High Prevalence of Congenital Heart Disease in Infants to Augment Growth of Fetal and Neonatal Monitoring Market

 


Fetal and neonatal monitoring is a technique of monitoring your newborn's heart and lungs before, during, and after he/she was born. Normally the mother passes all of her body functions to the baby via vaginal deliveries or breastfeeding. A monitor is inserted into the birth canal to detect any irregularities in breathing, heartbeat, or pumping. These monitors are also used in early detection of any problems associated with your unborn baby such as congenital heart disease, breathing difficulties, or infections.

Market Dynamics

High prevalence of congenital heart disease in infants is expected to propel growth of the fetal and neonatal monitoring market. For instance, according to the study, Prevalence, profile, and pattern of congenital heart disease in Central India: A prospective, observational study (published in May 2018), the prevalence of congenital heart disease (CHD) was 10.13/1000 live births. Moreover, emergence of Covid-19 is also expected to aid in growth of the market. For instance, in July 2020, Koninklijke Philips N.V. launched Avalon CL Fetal and Maternal Pod and Patch capable of providing “continuous non-invasive monitoring” of important vital signs such as maternal heart rate, fetal heart rate, and uterine activity.

High rate of maternal mortality in emerging economies is expected to offer lucrative growth opportunities for players in the fetal and neonatal monitoring market. For instance, according to Maternal Mortality: 1990 to 2015 Estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division, Sub-Saharan Africa recorded the highest ratio or maternal mortality, at 555 per 100, 000 live births, from 1990 to 2015. Moreover, the United Nations is focused on achieving the Sustainable Development Goals 2015 - 2030 global maternal mortality ratio target of less than 70 per 100 000 live births.

Among regions, North America is expected to witness significant growth in the fetal and neonatal monitoring market, owing to increasing preterm birth rate in the U.S. For instance, according to March of Dimes 2019 report card, the preterm birth rate in the U.S. reached 10.02% in 2018 from 9.63% in 2015.

Competitive Analysis

Major players operating in the fetal and neonatal monitoring market include, Becton, Dickinson and Company, Fujifilm SonoSite Inc., Medtronic Plc, Dragerwerk AG & Co. KGAA, Cooper Surgical, Getinge AB, MindChild Medical, Inc., Natus Medical Incorporated, GE Healthcare, Siemens Healthcare GmbH, ArjoHuntleigh, Inc., Neoventa Medical, Koninklijke Philips N.V., Analogic Corporation, Spacelabs Healthcare Inc., Smiths Medical, and Masimo.

Major players operating in the fetal and neonatal monitoring market are focused on adopting partnership strategies to enhance their market share. For instance, in April 2019, Henry Schein Medical, the U.S. Medical business of Henry Schein, Inc., and MindChild Medical, Inc. signed an exclusive distribution and supply agreement for the MERIDIAN M110 Fetal Monitoring System.

 

Labels:

Comments

Post a Comment

Popular posts from this blog

The Global Pressure Bandages Market Is Witnessing High Growth Owing To the Increasing Incidence of Surgical Processes in the World

  Market Overview: During a medical emergency, a pressure bandage is used to apply pressure to an area of the body to control bleeding and swelling. There are a variety of types of pressure bandages that can be used for different purposes. The bandage is made up of several parts, including an air bladder, a pad, a closure bar, and an applicator. A pressure bandage can be applied to wounds at any location on the body. This type of dressing is useful in treating various conditions, including gunshot wounds. It can also be used for a temporary holding of a hernia. The bandage is usually vacuum-sealed, so it's easier to carry. Competitive Landscape: Major players operating in the global pressure bandages market include ConvaTec Group PLC., Cardinal Health, 3M, B. Braun Melsungen AG, Lohmann & Rauscher GmbH & Co. KG, Mölnlycke Health Care AB, Smith & Nephew plc., Paul Hartmann AG, and Essity (BSN medical GmbH). Key Market Drivers: Increasing developments by key pla...
Post a Comment
Read more

Increasing Incidences of Infectious Diseases to Augment the Antibacterial Drugs Market Growth

  Antibacterial drugs are widely used to treat and prevent infectious diseases and are categorized into seven major classes, such as β-Lactams, phenicols, macrolides, quinolones, sulfonamides, tetracyclines, and aminoglycosides, based on their molecular structure. Antibacterial drugs destroy or slow down the growth of bacteria. These medications are also used to treat urinary infections caused by S. aureus, E. coli, Streptococcus pyogenes, and other bacterial infections. They include a range of powerful drugs used to treat diseases caused by bacteria. Antibiotics cannot treat viral infections, such as cold, flu, and most coughs. Antibacterial drugs play a major role in advanced healthcare, as they are widely used to treat infectious diseases, such as tuberculosis, malaria, typhoid, leprosy, hepatitis B, HIV/AIDS, and others. Thus, there is an increasing demand for antibacterial drugs worldwide.  
Post a Comment
Read more

Chromatography Market Development Analysis Contributing Top Vendor Landscape and Economic Growth 2028

  Chromatography is widely used in various life science applications. It finds application in the food industry for spoilage detection, additive detection, and determining nutritional quality. In forensics, it is used for crime scene testing and forensic pathology. Statistics: The global chromatography market is estimated to account for  US$ 13,465.2 Mn  in terms of value by the end of  2027 . Global Chromatography Market: Drivers Increasing prevalence of cancer is expected to propel growth of the global chromatography market over the forecast period. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.  
Post a Comment
Read more